Telemedicine-Based Emergency Physician Assessment Prior to ED Entry: A Randomized Controlled Trial

April 30, 2026 updated by: Avi Epstein, Sheba Medical Center

Randomized Controlled Trial Comparing the Safety and Efficiency of a Virtual-Hybrid Emergency Department Model Versus Standard Emergency Department Management in Non-Urgent Patients

Background:

Emergency department (ED) overcrowding is a growing challenge worldwide and is associated with prolonged length of stay (LOS), reduced patient satisfaction, and increased burden on healthcare systems. New approaches are needed to improve how patients are evaluated and treated.

Telemedicine has been increasingly integrated into ED care and has shown feasibility and benefits in various settings. Existing models have demonstrated improvements in patient flow, reduced length of stay, and high patient satisfaction. However, despite the growing use of telemedicine in emergency medicine, there is a lack of randomized controlled trials evaluating its effectiveness and safety, particularly in models involving early remote physician assessment prior to ED evaluation.

Purpose:

This study aims to evaluate whether a video consultation with a senior emergency physician before entering the ED can improve the efficiency and quality of care. The study also examines whether physicians can accurately identify which patients need ED evaluation based on a remote assessment, while maintaining patient safety.

Methods:

A total of 200 adults who arrived at the ED were assigned to one of two groups. In the study group, participants had a video consultation with a physician before continuing with standard ED care.

In the control group, participants received standard ED care only.

During the video consultation, the physician performed an initial clinical assessment and could order tests or specialist consultations. The physician was also asked what their recommendation would have been if the participant had been assessed from home. Three possible decisions were recorded:

  • Immediate ED presentation
  • Scheduled ED presentation at a later time
  • Continued care in the community without ED presentation

Outcomes:

The primary outcomes focus on the effectiveness of the intervention. These include:

  • ED length of stay
  • Patient satisfaction
  • The ability of physicians to accurately identify participants who require ED evaluation The secondary outcome is safety, assessed by return visits to the ED within one week for the same complaint.

Study Overview

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ramat Gan, Israel
        • Sheba Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18 years and older
  • Presentation to the emergency department during study recruitment hours
  • Ability to provide written informed consent

Exclusion Criteria:

  • Pregnancy
  • Arrival by ambulance
  • Severe pain, defined as a Visual Analogue Scale (VAS) score of 8 or higher
  • Emergency Severity Index (ESI) level 1 or 2
  • Language barriers or technological difficulties without an accompanying person able to assist
  • Isolated orthopedic complaints with suspected fracture or dislocation
  • Repeat emergency department visit for the same complaint within the previous 72 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study Group / Telemedicine Group
Participants undergo an initial video consultation with a senior emergency physician prior to continuing with standard emergency department care.
Participants undergo an initial video consultation with a senior emergency physician prior to continuing with standard emergency department care. The consultation includes a clinical assessment and may involve ordering diagnostic tests or specialist consultations.
No Intervention: Control Group
Participants receive standard emergency department care without a prior video consultation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emergency Department Length of Stay
Time Frame: From emergency department registration to the final decision regarding discharge or hospital admission during the index visit, up to 24 hours.
Emergency department length of stay, defined as the time from emergency department registration to discharge or hospital admission during the index visit, measured in hours. Data will be extracted from the hospital electronic medical record one week after the visit.
From emergency department registration to the final decision regarding discharge or hospital admission during the index visit, up to 24 hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Return Visits to the Emergency Department
Time Frame: Within one week after the ED visit
Return visits to the emergency department within one week for the same complaint.
Within one week after the ED visit
Accuracy of Physician Assessment for ED Referral
Time Frame: From the baseline physician assessment at the initial video consultation, to the final clinical outcome at the end of the index visit (discharge or hospital admission), up to 24 hours.
The ability of physicians to identify participants requiring emergency department evaluation based on the initial video consultation, assessed by comparing physician recommendations to actual clinical outcomes.
From the baseline physician assessment at the initial video consultation, to the final clinical outcome at the end of the index visit (discharge or hospital admission), up to 24 hours.
Patient Satisfaction
Time Frame: One week after the ED visit
Patient satisfaction will be assessed using the Short Assessment of Patient Satisfaction (SAPS) questionnaire, administered via SMS one week after the emergency department visit. The SAPS is a validated 7-item questionnaire that assesses multiple aspects of patient satisfaction. Total scores range from 0 to 28, with higher scores indicating greater patient satisfaction. Scores of 0 to 10 indicate Very dissatisfaction, 11 to 18 indicate dissatisfaction, 19 to 26 indicate satisfaction, and 27 to 28 indicate very high satisfaction.
One week after the ED visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 18, 2025

Primary Completion (Actual)

January 31, 2026

Study Completion (Actual)

January 31, 2026

Study Registration Dates

First Submitted

April 5, 2026

First Submitted That Met QC Criteria

April 19, 2026

First Posted (Actual)

April 22, 2026

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

April 30, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • SMC-2688-25

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telemedicine

Clinical Trials on Telemedicine-Based Remote Physician Assessment

Subscribe